Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 217

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

International Consensus Conference on Atopic Dermatitis II (ICCAD II*): clinical update and current treatment strategies

Open access
Ellis, C., Luger, T., the ICCAD II Faculty:, Abeck, D., Allen, R., Graham-Brown, R.A.C., de Prost, Y., Eichenfield, L.F., Ferrandiz, C., Giannetti, A., Hanifin, J., Koo, J.Y.M., Leung, D., Lynde, C., Ring, J., Ruiz-Maldonado, R., Saurat, J-H.·2003·British Journal of Dermatology

Abstract

* The first ICCAD meeting was held in Rome in 1999, the proceedings of which were published in the Journal of the American Academy of Dermatology (2001;45: S1−67). Atopic dermatitis (AD) is a common chronic relapsing inflammatory skin disease, characterized by intense itching, dry skin, inflammation and exudation. It causes physical and emotional distress for patients and their families. The first symptoms commonly develop in infancy, with around 50% of cases diagnosed by 1 year of age,1 and AD is typically a long‐term condition with at least one‐third of patients having persistent disease throughout adulthood. However the vast majority of cases of atopic dermatitis are mild in severity and usually can be managed easily.2 The disease is often familial and frequently associated with asthma, food allergy, allergic rhinitis and recurrent secondary skin infections. Atopic dermatitis has significant impact on quality of life in both children3 and adults.4 The impact is greater than with psoriasis and is equivalent to other serious medical conditions such as early onset of diabetes mellitus.5 The prevalence of atopic dermatitis has increased steadily in recent decades.4 In developed countries approximately 10–15% of children under 5 years of age are affected at some stage.4 The likelihood is that 60% of children with atopic dermatitis may recover free of the disease, the remainder having recurrences for long periods of time.6 It has also been suggested that the best prognosis for the disease is in those children who developed AD in the first year of life.7 However, overall the earlier the onset and the more severe the disease, there is a greater chance of persistence, especially with concurrent atopic disorders. Recent evidence has indicated a common pathophysiological link between severe atopic dermatitis, asthma and allergic rhinitis8, 9 (for example both asthma and AD are associated with increased IgE and eosinophilia). It has been suggested that atopic dermatitis may increase the subsequent risk or severity of asthma.10

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2133.148.s63.1.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 217

Metadata

Authors
Ellis, C., Luger, T., Faculty:, T. I. I., Abeck, D., Allen, R., Graham-Brown, R. A. C., de Prost, Y., Eichenfield, L. F., Ferrandiz, C., Giannetti, A., Hanifin, J., Koo, J. Y. M., Leung, D., Lynde, C., Ring, J., Ruiz-Maldonado, R., & Saurat, J.-H.
Venue
British Journal of Dermatology
Published
2003-05
Volume
148
Issue
s63
Pages
3-10
ISSN
  • 0007-0963 (ISSN-L)
  • 1365-2133
OpenAlex
W2053952900
Cited by
217
References
1
FWCI
18.64
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: International Consensus Conference on Atopic Dermatitis II (ICCAD II*): clinical update and current treatment strategies. https://app.cochat.ai/papers/10.1046/j.1365-2133.148.s63.1.x
The paper
Ellis, C., Luger, T., Faculty:, T. I. I., Abeck, D., Allen, R., Graham-Brown, R. A. C., de Prost, Y., Eichenfield, L. F., Ferrandiz, C., Giannetti, A., Hanifin, J., Koo, J. Y. M., Leung, D., Lynde, C., Ring, J., Ruiz-Maldonado, R., & Saurat, J.-H. (2003). International Consensus Conference on Atopic Dermatitis II (ICCAD II*): clinical update and current treatment strategies. British Journal of Dermatology. https://doi.org/10.1046/j.1365-2133.148.s63.1.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.